Navigation Links
Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells

Optimizing transfection conditions using LipoTAXI transfection reagent

Peter L. Pingerelli
Stratagene Cloning Systems

Soverin Karmiol
Clonetics Corporation, Walkersville, Maryland

LipoTAXI transfection reagent is a novel liposome reagent that offers low cellular toxicity and high transfection efficiencies for adherent and suspended cells. A procedure is described for optimizing the amounts of LipoTAXI transfection reagent and DNA used to transfect various cell types. Data from the transfection of four human cell strains from the Clonetics Corporation illustrate typical optimization results.

Many facets of gene analysis and recombinant protein expression rely on continuous development and improvement of transfection technology, the procedures for transferring foreign DNA into mammalian cells.1,2 LipoTAXI transfection reagent offers improved, state-of-the-art transfections for diverse cell types and can be used to transfect both adherent cells and cells growing in suspension. Generally, the two most important parameters for achieving optimal transfection efficiencies are the concentration of DNA and the volume of LipoTAXI transfection reagent. By measuring the signal intensity of a reporter gene and the cellular proteins across a matrix of conditions, researchers can easily optimize the amounts of DNA and LipoTAXI transfection reagent for any cell type.

Optimizing Transfection Conditions

The control plasmid provided with LipoTAXI transfection reagent encodes the beta-galactosidase enzyme controlled by the cytomegalovirus (CMV) promoter. Varying amounts of the reporter plasmid were mixed with different volumes of LipoTAXI transfection reagent and added to cells plated in 12-well culture dishes. For these optimization studies, Clonetics Corporation provided the following cell types: small airway epithelial cell
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
4. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
5. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
6. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. Efficient Transfection of Neurospora Crassa
9. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Low Toxicity Lipid Mediated Transfection Mammalian Cells

(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision ... tools to enable the broad use of genomic, imaging and ... the appointment of Michelle Munson , CEO of Aspera, ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
(Date:12/24/2014)... December 23, 2014 SoundConnect’s ... to introduce cutting edge communication technology, provide continued ... upgrades. This webinar series demonstrates online communication features ... leverage web conferencing’s most innovative and powerful tools. ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3
... Pharmaceuticals, Inc., a privately held drug development company, ... New Drug (IND) application with the U.S. Food ... anticancer compound. GGTI-2418 is a synthetic peptidomimetic ... to induce apoptosis by downregulating several pivotal oncogenic ...
... Advancing Core Lysosomal Storage Disorder Programs to Key Milestones ... 5 Amicus Therapeutics (Nasdaq: FOLD ) ... full year 2008. On a reported basis calculated in ... announced a net loss attributable to common stockholders of ...
... CALGARY, Feb. 5 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President ... ONCY ), will present a corporate overview ... America Conference on Monday, February 9, 2009 at 4:30 ... Westin Bayshore Resort in Vancouver, B.C. from February 8-10, ...
Cached Biology Technology:Tigris Pharmaceuticals Files IND Application for GGTI-2418 2Tigris Pharmaceuticals Files IND Application for GGTI-2418 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 4Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 5Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 6Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 7Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 8Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 9Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 10Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 11Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 12Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results 13Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America 2
(Date:12/11/2014)... 09, 2014 Research and Markets , ... ) has announced the addition of the "Biometrics ... offering. One major trend emerging in ... in technology, it is important to upgrade biometric solutions ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ...
(Date:12/10/2014)... here before: you desperately need to sign into your online banking ... to your secret question. What,s your dog,s birthday? Who was your ... a digital infrastructure security company, launches the app that ... usernames, passwords and PINs – 1U TM . 1U ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... As natural gas development expands nationwide, policymakers, communities ... impact assessments (HIA) as a means of predicting the ... new study from the Colorado School of Public Health. ... American Journal of Public Health , highlights lessons learned ...
... WHAT: ... Charitable Trusts as the "Biomedical Researcher of the Month," for his ... As a postdoctoral researcher in the Princeton University laboratory of Lynn ... type 1 (HSV-1)which, in rare cases, can lead to blindness or ...
... of the Philosophical Transactions of The Royal Society ... our society: feeding a global population that is simultaneously ... preventing widespread ecological and social impoverishment. According ... Hole Research Center (WHRC) and one of the issue,s ...
Cached Biology News:Health impact assessments prove critical public health tool 2Viral curiosity spreads across continents 2Ecology, economy and management of an agro-industrial Amazon frontier 2Ecology, economy and management of an agro-industrial Amazon frontier 3
... CultureWell cell culture chambered coverslips ... cells for staining and imaging. ... silicone gaskets with standard optical-quality ... and ready to use. Preassembled ...
... mL - 25 mL pipets ,Angled acrylic pipet ... standard square or round pipet cans. Constructed of 6 ... 76 mm W x 76 mm H x 289 ... Overall dimensions: 89 mm W x 406 mm H ...
... CultureWell cell culture systems provide an ... for staining and imaging. Each system ... standard optical-quality coverslips in cell culture ... sterile and ready to use. Individual ...
Request Info...
Biology Products: